Functional and patient‐reported changes in swallowing and voice after combined chemotherapy and radiotherapy for limited‐stage small‐cell lung cancer
- 21 July 2021
- journal article
- research article
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 65 (6) , 786-795
Abstract
Introduction: The purpose of this study was to describe the nature and impact of dysphagia and dysphonia in patients with limited‐stage small‐cell lung cancer (SCLC) before and after chemoradiation.Methods: A prospective cohort study was conducted on patients receiving chemoradiotherapy for limited‐stage SCLC. Patients received either 40, 45 or 50 Gy, commencing the second cycle of chemotherapy. Outcomes included: videofluoroscopy (VFSS) to investigate aspiration, swallowing function and oesophageal motility; oral intake limitations; patient‐reported dysphagia; and patient‐reported dysphonia. Data were collected before treatment and one, three and six months post‐treatment.Results: Twelve patients were enrolled. Oropharyngeal swallowing was safe and functional at all times. Three patients exhibited oesophageal motility disorders before treatment, and a further three post‐treatment. Oral intake was most compromised one month post‐treatment with five patients either tube dependent or eating very limited diets. At all other times patients were eating normal or near‐normal diets. Despite normal oropharyngeal swallowing on VFSS, three patients reported moderate or severe dysphagia one month post‐treatment. Three additional patients reported moderate or severe difficulties three and six months post‐treatment. Patients who reported dysphagia one month post‐treatment all received a mean and maximum oesophageal dose of ≥15.7 Gy and ≥42 Gy, respectively. Dose–response relationships were not apparent three and six months post‐treatment. Voice problems varied, with worst scores reported one month post‐treatment.Conclusions: This study identified discordance between observed swallowing function and patient‐reported problems, which has clinical implications for patient management, and highlights future research needs. Ongoing efforts to reduce mucosal toxicity in patients with lung cancer are essential.Keywords
All Related Versions
Funding Information
- Victorian Cancer Agency (Early Career Seed Grant (ECSG15024))
This publication has 30 references indexed in Scilit:
- Swallowing dysfunction in cancer patientsSupportive Care in Cancer, 2011
- The Dysphagia Handicap Index: Development and ValidationDysphagia, 2011
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- The nature and severity of voice disorders in lung cancer patientsLogopedics Phoniatrics Vocology, 2008
- Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patientsAnnals of Oncology, 2007
- Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results DatabaseJournal of Clinical Oncology, 2006
- Initial Psychometric Assessment of a Functional Oral Intake Scale for Dysphagia in Stroke PatientsArchives of Physical Medicine and Rehabilitation, 2005
- Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancerEuropean Journal of Clinical Nutrition, 2002
- Symptoms in Adults with Lung CancerJournal of Pain and Symptom Management, 2000
- Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and EtoposideNew England Journal of Medicine, 1999